Udayavni Special

Bengaluru’s Zydus Cadila to start phase II clinical trials of COVID-19 vaccine


PTI, Aug 5, 2020, 1:53 PM IST

New Delhi/Bengaluru: Drug firm Zydus Cadila on Wednesday, August 5 said the phase I clinical trial of its COVID-19 vaccine candidate, ZyCoV-D, has been completed and it will commence phase II clinical trials from August 6.

“ZyCoV-D was found to be safe and well-tolerated in phase I clinical trial. The company will now commence phase II clinical trials from the 6th of August, 2020. The company reports that the doses of the vaccine administered to healthy volunteers in phase I clinical trial, which began on July 15, 2020, has been well-tolerated,” Cadila Healthcare, the listed entity of the group, said in a regulatory filing.

Zydus Cadila Chairman Pankaj R Patel said the phase I dosing to establish the safety of ZyCoV-D is an important milestone.

“All the subjects in phase I clinical trial were closely monitored in a clinical pharmacological unit for 24 hours post-dosing for safety and for 7 days thereafter and the vaccine was found to be very safe. We now begin the phase II clinical trials and look forward to evaluating the safety and immunogenicity of the vaccine in a larger population,” he added.

Last month, Zydus had received approval from domestic authorities to start human trials for its COVID-19 vaccine contender – the second Indian pharmaceutical firm to get such nod amid a surge in novel coronavirus infections worldwide.

It got approval a few days after India”s first indigenous COVID-19 vaccine candidate COVAXIN, developed by city-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, got the nod for human clinical trials from the Drug Controller General of India

Shares of Cadila Healthcare were trading at Rs 407.20 apiece on BSE, up 1.08 percent from its previous close.

Top News

K’taka COVID-19 update: 6997 new cases, 5460 discharges, 38 deaths on Sep 22

MoS Railways Suresh Angadi passes away

Delhi Deputy CM Manish Sisodia hospitalised due to Covid-19

CMS gets contract from Karnataka Bank, Paytm for home delivery of cash

PM reviews COVID-19 situation with CMs, representatives of 7 states with high case load

NCB summons Deepika, Shraddha Kapoor, Sara Ali Khan in drugs case

Eiffel Tower evacuated over bomb threat




Related Articles More

K’taka COVID-19 update: 6997 new cases, 5460 discharges, 38 deaths on Sep 22

Covid-19: MLA Narayan Rao’s condition critical

Amid COVID-19 impact, Indian economy forecast to contract 5.4% in 2020: UN

Trump hits out at China for not stopping COVID-19; calls it Chinese virus yet again

Deputy CM Govind Karjol tests positive for COVID-19

MUST WATCH

‘Road Politics in Times of Pandemic’: St Aloysius Institution reacts to road renaming

Mangaluru Light House Hill Road renamed as Mulki Sunder Ram Shetty Road

Soraba : District Excise Department seized Millions worth of Marijuana | Udayavani

Hospet : Tungabhadra Dam Gates Are Opened | TB Dam | Udayavani

Surathkal: Police arrest four in house burglary case

Latest Additions

K’taka COVID-19 update: 6997 new cases, 5460 discharges, 38 deaths on Sep 22

MoS Railways Suresh Angadi passes away

Hanur: Police find sandalwood along with marijuana during raid

Mercedes Benz launches AMG GLE 53 4MATIC+ Coupe at Rs 1.2 cr

Kukke Subramanya temple to restart ritual offerings at evening

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.